Five-Year Outcomes With Nivolumab in Patients With Wild-Type <i>BRAF</i> Advanced MelanomaCaroline Robert, Victoria Atkinson, Célèste Lebbé et al.|Journal of Clinical Oncology|2020Cited by 226